Published in Eukaryot Cell on April 01, 2004
Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PLoS Pathog (2014) 1.98
Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev (2011) 1.90
Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog (2009) 1.76
Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell Microbiol (2008) 1.76
Epigenetic regulation of the nitrosative stress response and intracellular macrophage survival by extraintestinal pathogenic Escherichia coli. Mol Microbiol (2012) 1.35
Candida albicans transcription factor Ace2 regulates metabolism and is required for filamentation in hypoxic conditions. Eukaryot Cell (2006) 1.33
Mutation of the regulator of G protein signaling Crg1 increases virulence in Cryptococcus neoformans. Eukaryot Cell (2004) 1.30
Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother (2011) 1.21
Hosting infection: experimental models to assay Candida virulence. Int J Microbiol (2011) 1.14
Candida glabrata environmental stress response involves Saccharomyces cerevisiae Msn2/4 orthologous transcription factors. Mol Microbiol (2008) 1.13
From Saccharomyces cerevisiae to Candida glabratain a few easy steps: important adaptations for an opportunistic pathogen. FEMS Microbiol Lett (2010) 1.08
Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Mol Vis (2007) 1.05
The Aspergillus fumigatus transcription factor Ace2 governs pigment production, conidiation and virulence. Mol Microbiol (2009) 1.04
Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts. Infect Immun (2006) 1.01
The high-osmolarity glycerol response pathway in the human fungal pathogen Candida glabrata strain ATCC 2001 lacks a signaling branch that operates in baker's yeast. Eukaryot Cell (2007) 0.97
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B. Antimicrob Agents Chemother (2012) 0.96
The RAM network in pathogenic fungi. Eukaryot Cell (2012) 0.95
Genome duplication and mutations in ACE2 cause multicellular, fast-sedimenting phenotypes in evolved Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2013) 0.93
Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models. Microb Pathog (2007) 0.93
One small step for a yeast--microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutation. PLoS Pathog (2014) 0.87
Differential virulence of Candida glabrata glycosylation mutants. J Biol Chem (2013) 0.87
New insights into the structure of (1→3,1→6)-β-D-glucan side chains in the Candida glabrata cell wall. PLoS One (2011) 0.83
The Pneumocystis Ace2 transcription factor regulates cell wall-remodeling genes and organism virulence. J Biol Chem (2013) 0.82
The trans-kingdom identification of negative regulators of pathogen hypervirulence. FEMS Microbiol Rev (2015) 0.79
Amino acid-derived 1,2-benzisothiazolinone derivatives as novel small-molecule antifungal inhibitors: identification of potential genetic targets. Antimicrob Agents Chemother (2012) 0.78
A Small Protein Associated with Fungal Energy Metabolism Affects the Virulence of Cryptococcus neoformans in Mammals. PLoS Pathog (2016) 0.76
Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species Comparison. Front Cell Infect Microbiol (2016) 0.75
Transcriptional regulatory networks in Saccharomyces cerevisiae. Science (2002) 43.52
Innate immune recognition. Annu Rev Immunol (2001) 26.65
The immunopathogenesis of sepsis. Nature (2002) 11.83
Simultaneous identification of bacterial virulence genes by negative selection. Science (1995) 10.52
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis (1993) 8.63
The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis (1997) 7.09
Immunosuppressive effects of apoptotic cells. Nature (1997) 7.03
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med (1988) 4.69
Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis (1995) 3.69
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis (2002) 3.46
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis (1999) 3.39
Fungal morphogenesis and host invasion. Curr Opin Microbiol (2002) 3.01
Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis (1997) 2.67
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol (1999) 1.98
Hypervirulence and pathogen fitness. Trends Microbiol (2003) 1.89
Overlapping and distinct roles of the duplicated yeast transcription factors Ace2p and Swi5p. Mol Microbiol (2001) 1.82
ACE2, an activator of yeast metallothionein expression which is homologous to SWI5. Mol Cell Biol (1991) 1.76
Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol Microbiol (2001) 1.74
Virulence genes in the pathogenic yeast Candida albicans. FEMS Microbiol Rev (2001) 1.64
Regulated nuclear localisation of the yeast transcription factor Ace2p controls expression of chitinase (CTS1) in Saccharomyces cerevisiae. Mol Gen Genet (1999) 1.55
Isolation of a Candida glabrata centromere and its use in construction of plasmid vectors. Gene (1996) 1.41
Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med (2000) 1.36
Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg (1997) 1.31
A Saccharomyces cerevisiae mutant with increased virulence. Proc Natl Acad Sci U S A (2003) 1.23
Virulence in Candida species. Trends Microbiol (2001) 1.14
A GAS-like gene family in the pathogenic fungus Candida glabrata. Microbiology (2001) 1.01
Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation. Mol Microbiol (2003) 0.98
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med (2002) 17.04
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2008) 16.51
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (2005) 8.55
Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature (2005) 7.74
Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10
Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol (2006) 6.36
Genome sequencing and analysis of Aspergillus oryzae. Nature (2005) 5.47
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis (2009) 4.71
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis (2006) 4.42
A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis. BMC Evol Biol (2006) 4.03
Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet (2008) 3.23
Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med (2004) 2.90
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis (2004) 2.89
Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol (2012) 2.68
Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat (2009) 2.63
Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat (2006) 2.53
Adverse reactions to voriconazole. Clin Infect Dis (2004) 2.51
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis (2003) 2.49
Tackling human fungal infections. Science (2012) 2.49
Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol (2005) 2.42
TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys. PLoS Pathog (2010) 2.33
Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents (2006) 2.30
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2011) 2.27
Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res (2009) 2.24
Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol (2003) 2.18
Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. PLoS Pathog (2007) 2.17
Gene order evolution and paleopolyploidy in hemiascomycete yeasts. Proc Natl Acad Sci U S A (2002) 2.16
Evidence for sexuality in the opportunistic fungal pathogen Aspergillus fumigatus. Curr Biol (2005) 2.12
Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathog (2008) 2.09
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem (2005) 2.05
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother (2010) 2.03
Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol (2003) 1.90
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis (2010) 1.83
Ambient pH gene regulation in fungi: making connections. Trends Microbiol (2008) 1.83
Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum (2004) 1.82
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother (2006) 1.71
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma (2012) 1.67
The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol Microbiol (2004) 1.66
Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol (2002) 1.66
Functional microRNA is transferred between glioma cells. Cancer Res (2010) 1.63
In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp. J Antimicrob Chemother (2005) 1.61
Yeast genome evolution--the origin of the species. Yeast (2007) 1.60
Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem (2002) 1.58
Do chest compressions during simulated infant CPR comply with international recommendations? Arch Dis Child (2012) 1.56
Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope (2009) 1.54
Evidence from comparative genomics for a complete sexual cycle in the 'asexual' pathogenic yeast Candida glabrata. Genome Biol (2003) 1.52
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett (2013) 1.51
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol Cell Biol (2007) 1.50
IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest (2013) 1.46
Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis (2003) 1.44
A cautionary tale: Lack of consistency in allele sizes between two laboratories for a published multilocus microsatellite typing system. J Clin Microbiol (2006) 1.43
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2). J Clin Microbiol (2006) 1.43
Postdeployment mental health screening: an application of the Soldier Adaptation Model. Mil Med (2012) 1.41
Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot Cell (2006) 1.41
Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect. Antimicrob Agents Chemother (2009) 1.41
Pinch-an-inch test for appendicitis. South Med J (2005) 1.38
TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity. Virology (2005) 1.38
Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med (2005) 1.37
MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. Cancer Invest (2010) 1.35
Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA. Mol Microbiol (2008) 1.35
Candida albicans transcription factor Ace2 regulates metabolism and is required for filamentation in hypoxic conditions. Eukaryot Cell (2006) 1.33
Analysis of gene evolution and metabolic pathways using the Candida Gene Order Browser. BMC Genomics (2010) 1.33
Insight into the genome of Aspergillus fumigatus: analysis of a 922 kb region encompassing the nitrate assimilation gene cluster. Fungal Genet Biol (2004) 1.33
A genome sequence survey shows that the pathogenic yeast Candida parapsilosis has a defective MTLa1 allele at its mating type locus. Eukaryot Cell (2005) 1.30
CO2 sensing in fungi and beyond. Curr Opin Microbiol (2006) 1.30
Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr (2011) 1.29
The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother (2013) 1.29
Nitrosative and oxidative stress responses in fungal pathogenicity. Curr Opin Microbiol (2009) 1.28
Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis (2008) 1.27
Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob Agents Chemother (2004) 1.25
Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology (2005) 1.23
The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen. Mol Microbiol (2004) 1.21
The Aspergillus pH-responsive transcription factor PacC regulates virulence. Mol Microbiol (2005) 1.20
Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis (2009) 1.19
The quorum-sensing molecules farnesol/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicans. Eukaryot Cell (2011) 1.18
Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J Clin Microbiol (2010) 1.17
Two zinc finger transcription factors, CrzA and SltA, are involved in cation homoeostasis and detoxification in Aspergillus nidulans. Biochem J (2008) 1.17
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida. J Antimicrob Chemother (2004) 1.16
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med (2006) 1.16
Comparative genome analysis and gene finding in Candida species using CGOB. Mol Biol Evol (2013) 1.16
Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr Infect Dis J (2013) 1.15
Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography. Thorax (2011) 1.15
CO(2) acts as a signalling molecule in populations of the fungal pathogen Candida albicans. PLoS Pathog (2010) 1.15
Genomic insights into the atopic eczema-associated skin commensal yeast Malassezia sympodialis. MBio (2013) 1.15
Sensing the environment: response of Candida albicans to the X factor. FEMS Microbiol Lett (2009) 1.14
Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot Cell (2007) 1.14
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc Natl Acad Sci U S A (2011) 1.13
Candida glabrata environmental stress response involves Saccharomyces cerevisiae Msn2/4 orthologous transcription factors. Mol Microbiol (2008) 1.13
Regulation of the hypoxic response in Candida albicans. Eukaryot Cell (2010) 1.11
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis. Antimicrob Agents Chemother (2006) 1.11
Using RNA-seq to determine the transcriptional landscape and the hypoxic response of the pathogenic yeast Candida parapsilosis. BMC Genomics (2011) 1.10